The world’s most intelligent rapid detection software for TBI.
Cerebro's AI and spatial computing systems specialize in the early detection and treatment of neurocognitive disease.
EXPERIMENTAL RESEARCH PHASE: The Cerebro AI/ML Neural Net is not yet cleared or approved by the U.S. Food and Drug Administration (FDA) for commercial distribution. The device is currently in the research phase and is not available for sale or distribution in the United States. This device is intended For Research Use Only.